Paper6909683
Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
Betkerur MV and 4 others. Pediatrics, 1981. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Papers, record 6909683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6909683
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ductus Arteriosus, Patent | Major topic |
| Indomethacin | Major topic |
| Infant, Premature | Major topic |
| Kallikreins | Major topic |
| Kidney | Major topic |
| Electrolytes | |
| Glomerular Filtration Rate | |
| Humans | |
| Infant, Newborn |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33448032 | Indomethacin for symptomatic patent ductus arteriosus in preterm infants. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/33448032 | PubMed |
| 33301630 | Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/33301630 | PubMed |
| 31985838 | Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/31985838 | PubMed |
| 31222841 | Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31222841 | PubMed |
| 29584842 | Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis. | JAMA | 2018 | https://conductscience.org/library/papers/29584842 | PubMed |
| 25035813 | A Potential Biomarker for Acute Kidney Injury in Preterm Infants from Metabolic Profiling. | J Mol Biomark Diagn | 2012 | https://conductscience.org/library/papers/25035813 | PubMed |
| 23543527 | Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23543527 | PubMed |
| 23128963 | Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23128963 | PubMed |
| 22189742 | Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns? | Clinics (Sao Paulo) | 2011 | https://conductscience.org/library/papers/22189742 | PubMed |
| 21718490 | Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. | BMC Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21718490 | PubMed |
| 20614421 | Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20614421 | PubMed |
| 12804488 | Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. | Cochrane Database Syst Rev | 2003 | https://conductscience.org/library/papers/12804488 | PubMed |
| 12765488 | Nonsteroidal anti-inflammatory agents in neonates. | Paediatr Drugs | 2003 | https://conductscience.org/library/papers/12765488 | PubMed |
| 12032793 | Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant. | J Perinatol | 2002 | https://conductscience.org/library/papers/12032793 | PubMed |
| 11219488 | NSAID-induced nephrotoxicity from the fetus to the child. | Drug Saf | 2001 | https://conductscience.org/library/papers/11219488 | PubMed |
| 8092906 | Forty-six years of patient ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison. | Ann Surg | 1994 | https://conductscience.org/library/papers/8092906 | PubMed |
| 3293867 | Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II). | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3293867 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KLK4 | 9622 | PubTator's text mining | https://conductscience.org/library/genes/9622 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6909683
GET https://conductscience.org/api/papers/v1/6909683/authors